Results 51 to 60 of about 287,756 (345)

Microbiome distinctions between the CRC carcinogenic pathways

open access: yesGut Microbes, 2021
Colorectal cancer (CRC) is the third most commonly diagnosed cancer, the third leading cause of cancer-related deaths, and has been on the rise among young adults in the United States.
Lauren DeDecker   +4 more
doaj   +1 more source

Plasmacytoid myoepithelioma arising in hard palate – A rare case report

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2022
Myoepithelioma, which is benign, is a salivary gland neoplasm representing 1.5% of all the neoplasms of salivary glands. The commonest location of its occurrence is parotid gland.
Trupti V Gaikwad   +3 more
doaj   +1 more source

Determination of ADP/ATP translocase isoform ratios in malignancy and cellular senescence

open access: yesMolecular Oncology, EarlyView.
The individual functions of three isoforms exchanging ADP and ATP (ADP/ATP translocases; ANTs) on the mitochondrial membrane remain unclear. We developed a method for quantitatively differentiating highly similar human ANT1, ANT2, and ANT3 using parallel reaction monitoring. This method allowed us to assess changes in translocase levels during cellular
Zuzana Liblova   +18 more
wiley   +1 more source

Surgery for acromegaly: Indications and goals

open access: yesFrontiers in Endocrinology, 2022
Acromegaly is a disease that occurs secondary to high levels of GH, most often from a hormone-secreting pituitary adenoma, with multisystem adverse effects.
David P. Bray   +4 more
doaj   +1 more source

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

open access: yesMolecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias   +12 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

The Parathyroid Adenoma

open access: yesArchives of Clinical and Experimental Surgery, 2014
Parathyroid adenomas are benign neoplasms with a predilection for the inferior parathyroid glands. Genetic mutations identified as contributing to development of parathyroid adenomas include MEN 1 and cyclin D1. Predisposing factors include female gender
Ali Cadili
doaj   +1 more source

Evolving pathologic concepts of serrated lesions of the colorectum [PDF]

open access: yesJournal of Pathology and Translational Medicine, 2020
Here, we provide an up-to-date review of the histopathology and molecular pathology of serrated colorectal lesions. First, we introduce the updated contents of the 2019 World Health Organization classification for serrated lesions.
Jung Ho Kim, Gyeong Hoon Kang
doaj   +1 more source

Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.

open access: yesOncology Report, 2016
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in Japan. The etiology of CRC has been linked to numerous factors including genetic mutation, diet, life style, inflammation, and recently, the gut microbiota.
Chika Kasai   +10 more
semanticscholar   +1 more source

Liver‐specific lncRNAs associated with liver cancers

open access: yesFEBS Open Bio, EarlyView.
Long non‐coding RNAs (lncRNAs) are regulatory molecules with various functions. They are more tissue‐specific than proteins and can be used as potential biomarkers, particularly in cancer diagnostics and prognosis. In this review, we have systematically compiled all lncRNAs with exclusive expression in the human liver, verified their liver specificity ...
Olga Y. Burenina   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy